chr8-12112973-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001039615.3(ZNF705D):c.718T>A(p.Ser240Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001039615.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF705D | NM_001039615.3 | c.718T>A | p.Ser240Thr | missense_variant | 7/7 | ENST00000400085.8 | NP_001034704.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF705D | ENST00000400085.8 | c.718T>A | p.Ser240Thr | missense_variant | 7/7 | 5 | NM_001039615.3 | ENSP00000382957 | P1 |
Frequencies
GnomAD3 genomes Cov.: 11
GnomAD4 exome Cov.: 22
GnomAD4 genome Cov.: 11
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 01, 2022 | The c.718T>A (p.S240T) alteration is located in exon 7 (coding exon 5) of the ZNF705D gene. This alteration results from a T to A substitution at nucleotide position 718, causing the serine (S) at amino acid position 240 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.